Safety concerns over popular arthritis drug The TGA issued an alert after a study found high doses of tofacitinib could lead to increased risk of blood clots in the lungs and potentially death.
TGA moves to ease fears over a ‘no deal’ Brexit Imported medicines and devices will be minimally affected under a ‘no deal’ Brexit, according to the Therapeutic Goods Administration.
Commercial sensitivity or patient protection? Secrecy and medicine safety Researchers have identified an information gap between pharmacological companies and Australian clinicians on the potential safety risks of medicines.
The good, the bad and the dangerous: Advising on healthcare apps How can GPs and patients distinguish the helpful from the useless – or even harmful – among the ever-increasing flood of healthcare apps?
TGA changes offer greater protection from misleading advertising The TGA intends its updated code to provide consumers improved protection from misleading advertising of therapeutic goods.
Greg Hunt proposes changes to reporting scheme to help address medicine shortages The Federal Health Minister wants to make the reporting scheme mandatory rather than voluntary, with legal definitions of medicine shortage and penalties for non-compliance.
Unfounded claims about complementary medicine put patients in danger: RACGP Proposed legislation to legalise un-scientific claims on complementary medicines will place Australian patients at risk and must not come into force, Chair of the RACGP Expert Committee – Quality Care Dr Evan Ackermann told newsGP.
Transvaginal mesh implants inquiry: What GPs need to know Dr Magdalena Simonis – GP and RACGP representative on the recent Senate inquiry into transvaginal mesh implants – writes for newsGP about the outcomes of the inquiry, and what they mean for GPs and their patients.
Unfounded and unscientific claims have no place in legitimate healthcare RACGP President Dr Bastian Seidel expresses his dismay at news of the approval of the Therapeutic Goods Administration’s list of ‘permitted indications’.
Alarming health claims must not appear on complementary medicine: RACGP President Many of the items included on the Therapeutic Goods Administration’s list of ‘permitted indications’ make unfounded and unscientific claims that could lead to patient harms, RACGP President Dr Bastian Seidel writes for newsGP.